Trials / Recruiting
RecruitingNCT03849963
Imaging Oxidative Metabolism and Neurotransmitter Synthesis in the Human Brain
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 28 (estimated)
- Sponsor
- University of Texas Southwestern Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
Investigators propose to develop hyperpolarized \[13C\]-labeled pyruvate as potential imaging probes to assess two essential in vivo processes in cerebral metabolism: oxidative metabolism and synthesis of a neurotransmitter in this observational study.
Detailed description
Investigators will perform a pilot study to test the translational feasibility by evaluating sensitivity and repeatability of hyperpolarized \[1-13C\]pyruvate and \[2-13C\]pyruvate in healthy human subjects (n =10 each). Each subject will be imaged twice using the same hyperpolarized substrate with an interval (\<45min) between the injections to evaluate repeatability. Finally, eight subjects will be imaged with both hyperpolarized \[1-13C\]pyruvate and \[2-13C\]pyruvate for comparison.
Conditions
Timeline
- Start date
- 2030-07-30
- Primary completion
- 2030-12-31
- Completion
- 2030-12-31
- First posted
- 2019-02-21
- Last updated
- 2026-03-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03849963. Inclusion in this directory is not an endorsement.